Clinical Study
Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators
Table 2
Significant Pearson correlations for clinical factors and inflammatory markers change with treatment.
| Before intensive treatment | HSP60 | IL-10 | IL-12 | TNFα | BMI |
| −IL-12 0.040 | −HSP60 0.051 | −HSP60 0.040 | + IL-12 0.014 | + Waist 0.005 | −IL-10 0.051 | +IL-12 0.030 | +IL-10 0.030 | | | +IL-6 0.055 | | +TNFα 0.014 | | |
| After Intensive treatment | TNFα | HOMA | BMI | | |
| +HSP60 0.055 | −IL-10 0.009 | +Waist 0.010 | | | +IL-12 0.023 | | | | |
|
|
+ is positive correlation, − negative correlation. Number on right is value.
|